Global Prostate Cancer Screening Market Size, Status and Forecast 2021-2027

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Prostate Cancer Screening Market Size Growth Rate by Type ( 2016-2027)
1.4.2 Physical Exam
1.4.3 Laboratory Tests
1.4.4 Imaging Tests
1.4.5 Gleason Score
1.4.6 TNM Score
1.4.7 Genetic Tests
1.4.8 Digital Rectal Exam
1.4.9 Biopsy
1.5 Market by Application
1.5.1 Global Prostate Cancer Screening Market Share by Application ( 2016-2027)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Labs
1.5.5 Cancer Institutes
1.5.6 Diagnostic Centers
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Prostate Cancer Screening Market Size
2.2 Prostate Cancer Screening Growth Trends by Regions
2.2.1 Prostate Cancer Screening Market Size by Regions ( 2016-2027)
2.2.2 Prostate Cancer Screening Market Share by Regions ( 2016-2021)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Prostate Cancer Screening Market Size by Manufacturers
3.1.1 Global Prostate Cancer Screening Revenue by Manufacturers ( 2016-2021)
3.1.2 Global Prostate Cancer Screening Revenue Market Share by Manufacturers ( 2016-2021)
3.1.3 Global Prostate Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.2 Prostate Cancer Screening Key Players Head office and Area Served
3.3 Key Players Prostate Cancer Screening Product/Solution/Service
3.4 Date of Enter into Prostate Cancer Screening Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Prostate Cancer Screening Market Size by Type ( 2016-2021)
4.2 Global Prostate Cancer Screening Market Size by Application ( 2016-2021)

5 United States
5.1 United States Prostate Cancer Screening Market Size ( 2016-2021)
5.2 Prostate Cancer Screening Key Players in United States
5.3 United States Prostate Cancer Screening Market Size by Type
5.4 United States Prostate Cancer Screening Market Size by Application

6 Europe
6.1 Europe Prostate Cancer Screening Market Size ( 2016-2021)
6.2 Prostate Cancer Screening Key Players in Europe
6.3 Europe Prostate Cancer Screening Market Size by Type
6.4 Europe Prostate Cancer Screening Market Size by Application

7 China
7.1 China Prostate Cancer Screening Market Size ( 2016-2021)
7.2 Prostate Cancer Screening Key Players in China
7.3 China Prostate Cancer Screening Market Size by Type
7.4 China Prostate Cancer Screening Market Size by Application

8 Japan
8.1 Japan Prostate Cancer Screening Market Size ( 2016-2021)
8.2 Prostate Cancer Screening Key Players in Japan
8.3 Japan Prostate Cancer Screening Market Size by Type
8.4 Japan Prostate Cancer Screening Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Prostate Cancer Screening Market Size ( 2016-2021)
9.2 Prostate Cancer Screening Key Players in Southeast Asia
9.3 Southeast Asia Prostate Cancer Screening Market Size by Type
9.4 Southeast Asia Prostate Cancer Screening Market Size by Application

10 India
10.1 India Prostate Cancer Screening Market Size ( 2016-2021)
10.2 Prostate Cancer Screening Key Players in India
10.3 India Prostate Cancer Screening Market Size by Type
10.4 India Prostate Cancer Screening Market Size by Application

11 Central & South America
11.1 Central & South America Prostate Cancer Screening Market Size ( 2016-2021)
11.2 Prostate Cancer Screening Key Players in Central & South America
11.3 Central & South America Prostate Cancer Screening Market Size by Type
11.4 Central & South America Prostate Cancer Screening Market Size by Application

12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Prostate Cancer Screening Introduction
12.1.4 Abbott Laboratories Revenue in Prostate Cancer Screening Business ( 2016-2021)
12.1.5 Abbott Laboratories Recent Development
12.2 Almac
12.2.1 Almac Company Details
12.2.2 Company Description and Business Overview
12.2.3 Prostate Cancer Screening Introduction
12.2.4 Almac Revenue in Prostate Cancer Screening Business ( 2016-2021)
12.2.5 Almac Recent Development
12.3 Bayer
12.3.1 Bayer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Prostate Cancer Screening Introduction
12.3.4 Bayer Revenue in Prostate Cancer Screening Business ( 2016-2021)
12.3.5 Bayer Recent Development
12.4 Beckman Coulter
12.4.1 Beckman Coulter Company Details
12.4.2 Company Description and Business Overview
12.4.3 Prostate Cancer Screening Introduction
12.4.4 Beckman Coulter Revenue in Prostate Cancer Screening Business ( 2016-2021)
12.4.5 Beckman Coulter Recent Development
12.5 Biom�Rieux
12.5.1 Biom�Rieux Company Details
12.5.2 Company Description and Business Overview
12.5.3 Prostate Cancer Screening Introduction
12.5.4 Biom�Rieux Revenue in Prostate Cancer Screening Business ( 2016-2021)
12.5.5 Biom�Rieux Recent Development
12.6 Genomic Health
12.6.1 Genomic Health Company Details
12.6.2 Company Description and Business Overview
12.6.3 Prostate Cancer Screening Introduction
12.6.4 Genomic Health Revenue in Prostate Cancer Screening Business ( 2016-2021)
12.6.5 Genomic Health Recent Development
12.7 Mayo Clinic
12.7.1 Mayo Clinic Company Details
12.7.2 Company Description and Business Overview
12.7.3 Prostate Cancer Screening Introduction
12.7.4 Mayo Clinic Revenue in Prostate Cancer Screening Business ( 2016-2021)
12.7.5 Mayo Clinic Recent Development
12.8 Mdxhealth
12.8.1 Mdxhealth Company Details
12.8.2 Company Description and Business Overview
12.8.3 Prostate Cancer Screening Introduction
12.8.4 Mdxhealth Revenue in Prostate Cancer Screening Business ( 2016-2021)
12.8.5 Mdxhealth Recent Development
12.9 Roche Diagnostics
12.9.1 Roche Diagnostics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Prostate Cancer Screening Introduction
12.9.4 Roche Diagnostics Revenue in Prostate Cancer Screening Business ( 2016-2021)
12.9.5 Roche Diagnostics Recent Development
12.10 Rosetta Genomics
12.10.1 Rosetta Genomics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Prostate Cancer Screening Introduction
12.10.4 Rosetta Genomics Revenue in Prostate Cancer Screening Business ( 2016-2021)
12.10.5 Rosetta Genomics Recent Development
12.11 Thermo Fisher Scientific
12.12 Hologic
12.13 Myriad Genetics

13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product ( 2021-2027)
13.10 Market Size Forecast by Application ( 2021-2027)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Prostate Cancer Screening Key Market Segments
Table Key Players Prostate Cancer Screening Covered
Table Global Prostate Cancer Screening Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Prostate Cancer Screening Market Size Market Share by Type 2016-2027
Figure Physical Exam Figures
Table Key Players of Physical Exam
Figure Laboratory Tests Figures
Table Key Players of Laboratory Tests
Figure Imaging Tests Figures
Table Key Players of Imaging Tests
Figure Gleason Score Figures
Table Key Players of Gleason Score
Figure TNM Score Figures
Table Key Players of TNM Score
Figure Genetic Tests Figures
Table Key Players of Genetic Tests
Figure Digital Rectal Exam Figures
Table Key Players of Digital Rectal Exam
Figure Biopsy Figures
Table Key Players of Biopsy
Table Global Prostate Cancer Screening Market Size Growth by Application 2016-2027 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Research Labs Case Studies
Figure Cancer Institutes Case Studies
Figure Diagnostic Centers Case Studies
Figure Others Case Studies
Figure Prostate Cancer Screening Report Years Considered
Table Global Prostate Cancer Screening Market Size 2016-2027 (Million US$)
Figure Global Prostate Cancer Screening Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Prostate Cancer Screening Market Size by Regions 2016-2027 (Million US$)
Table Global Prostate Cancer Screening Market Size by Regions 2016-2021 (Million US$)
Table Global Prostate Cancer Screening Market Share by Regions 2016-2021
Figure Global Prostate Cancer Screening Market Share by Regions 2016-2021
Figure Global Prostate Cancer Screening Market Share by Regions 2019
Table Market Top Trends
Table Global Prostate Cancer Screening Revenue by Manufacturers ( 2016-2021) (Million US$)
Table Global Prostate Cancer Screening Market Share by Manufacturers ( 2016-2021)
Figure Global Prostate Cancer Screening Market Share by Manufacturers in 2020
Table Global Prostate Cancer Screening Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Prostate Cancer Screening Product/Solution/Service
Table Date of Enter into Prostate Cancer Screening Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Prostate Cancer Screening Market Size by Type ( 2016-2021) (Million US$)
Table Global Prostate Cancer Screening Market Size Share by Type ( 2016-2021)
Figure Global Prostate Cancer Screening Market Size Market Share by Type ( 2016-2021)
Table Global Prostate Cancer Screening Market Size by Application ( 2016-2021) (Million US$)
Table Global Prostate Cancer Screening Market Size Share by Application ( 2016-2021)
Figure Global Prostate Cancer Screening Market Size Market Share by Application ( 2016-2021)
Figure Global Prostate Cancer Screening Revenue Market Share by Application in 2020
Figure United States Prostate Cancer Screening Market Size 2016-2021 (Million US$)
Table United States Key Players Prostate Cancer Screening Revenue ( 2020-2021) (Million US$)
Table United States Key Players Prostate Cancer Screening Market Share ( 2020-2021)
Table United States Prostate Cancer Screening Market Size by Type ( 2016-2021) (Million US$)
Table United States Prostate Cancer Screening Market Share by Type ( 2016-2021)
Table United States Prostate Cancer Screening Market Size by Application ( 2016-2021) (Million US$)
Table United States Prostate Cancer Screening Market Share by Application ( 2016-2021)
Figure Europe Prostate Cancer Screening Market Size 2016-2021 (Million US$)
Table Europe Key Players Prostate Cancer Screening Revenue ( 2020-2021) (Million US$)
Table Europe Key Players Prostate Cancer Screening Market Share ( 2020-2021)
Table Europe Prostate Cancer Screening Market Size by Type ( 2016-2021) (Million US$)
Table Europe Prostate Cancer Screening Market Share by Type ( 2016-2021)
Table Europe Prostate Cancer Screening Market Size by Application ( 2016-2021) (Million US$)
Table Europe Prostate Cancer Screening Market Share by Application ( 2016-2021)
Figure China Prostate Cancer Screening Market Size 2016-2021 (Million US$)
Table China Key Players Prostate Cancer Screening Revenue ( 2020-2021) (Million US$)
Table China Key Players Prostate Cancer Screening Market Share ( 2020-2021)
Table China Prostate Cancer Screening Market Size by Type (2014- 20209) (Million US$)
Table China Prostate Cancer Screening Market Share by Type ( 2016-2021)
Table China Prostate Cancer Screening Market Size by Application ( 2016-2021) (Million US$)
Table China Prostate Cancer Screening Market Share by Application ( 2016-2021)
Figure Japan Prostate Cancer Screening Market Size 2016-2021 (Million US$)
Table Japan Key Players Prostate Cancer Screening Revenue ( 2020-2021) (Million US$)
Table Japan Key Players Prostate Cancer Screening Market Share ( 2020-2021)
Table Japan Prostate Cancer Screening Market Size by Type ( 2016-2021) (Million US$)
Table Japan Prostate Cancer Screening Market Share by Type ( 2016-2021)
Table Japan Prostate Cancer Screening Market Size by Application ( 2016-2021) (Million US$)
Table Japan Prostate Cancer Screening Market Share by Application ( 2016-2021)
Figure Southeast Asia Prostate Cancer Screening Market Size 2016-2021 (Million US$)
Table Southeast Asia Key Players Prostate Cancer Screening Revenue ( 2020-2021) (Million US$)
Table Southeast Asia Key Players Prostate Cancer Screening Market Share ( 2020-2021)
Table Southeast Asia Prostate Cancer Screening Market Size by Type ( 2016-2021) (Million US$)
Table Southeast Asia Prostate Cancer Screening Market Share by Type ( 2016-2021)
Table Southeast Asia Prostate Cancer Screening Market Size by Application ( 2016-2021) (Million US$)
Table Southeast Asia Prostate Cancer Screening Market Share by Application ( 2016-2021)
Figure India Prostate Cancer Screening Market Size 2016-2021 (Million US$)
Table India Key Players Prostate Cancer Screening Revenue ( 2020-2021) (Million US$)
Table India Key Players Prostate Cancer Screening Market Share ( 2020-2021)
Table India Prostate Cancer Screening Market Size by Type ( 2016-2021) (Million US$)
Table India Prostate Cancer Screening Market Share by Type ( 2016-2021)
Table India Prostate Cancer Screening Market Size by Application ( 2016-2021) (Million US$)
Table India Prostate Cancer Screening Market Share by Application ( 2016-2021)
Figure Central & South America Prostate Cancer Screening Market Size 2016-2021 (Million US$)
Table Central & South America Key Players Prostate Cancer Screening Revenue ( 2020-2021) (Million US$)
Table Central & South America Key Players Prostate Cancer Screening Market Share ( 2020-2021)
Table Central & South America Prostate Cancer Screening Market Size by Type ( 2016-2021) (Million US$)
Table Central & South America Prostate Cancer Screening Market Share by Type ( 2016-2021)
Table Central & South America Prostate Cancer Screening Market Size by Application ( 2016-2021) (Million US$)
Table Central & South America Prostate Cancer Screening Market Share by Application ( 2016-2021)
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Prostate Cancer Screening Business ( 2016-2021) (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Prostate Cancer Screening Business ( 2016-2021)
Table Abbott Laboratories Recent Development
Table Almac Company Details
Table Almac Revenue in Prostate Cancer Screening Business ( 2016-2021)(Million US$)
Figure Almac Revenue Growth Rate in Prostate Cancer Screening Business ( 2016-2021)
Table Almac Recent Development
Table Bayer Company Details
Table Bayer Revenue in Prostate Cancer Screening Business ( 2016-2021)(Million US$)
Figure Bayer Revenue Growth Rate in Prostate Cancer Screening Business ( 2016-2021)
Table Bayer Recent Development
Table Beckman Coulter Company Details
Table Beckman Coulter Revenue in Prostate Cancer Screening Business ( 2016-2021)(Million US$)
Figure Beckman Coulter Revenue Growth Rate in Prostate Cancer Screening Business ( 2016-2021)
Table Beckman Coulter Recent Development
Table Biom�Rieux Company Details
Table Biom�Rieux Revenue in Prostate Cancer Screening Business ( 2016-2021)(Million US$)
Figure Biom�Rieux Revenue Growth Rate in Prostate Cancer Screening Business ( 2016-2021)
Table Biom�Rieux Recent Development
Table Genomic Health Company Details
Table Genomic Health Revenue in Prostate Cancer Screening Business ( 2016-2021)(Million US$)
Figure Genomic Health Revenue Growth Rate in Prostate Cancer Screening Business ( 2016-2021)
Table Genomic Health Recent Development
Table Mayo Clinic Company Details
Table Mayo Clinic Revenue in Prostate Cancer Screening Business ( 2016-2021)(Million US$)
Figure Mayo Clinic Revenue Growth Rate in Prostate Cancer Screening Business ( 2016-2021)
Table Mayo Clinic Recent Development
Table Mdxhealth Company Details
Table Mdxhealth Revenue in Prostate Cancer Screening Business ( 2016-2021)(Million US$)
Figure Mdxhealth Revenue Growth Rate in Prostate Cancer Screening Business ( 2016-2021)
Table Mdxhealth Recent Development
Table Roche Diagnostics Company Details
Table Roche Diagnostics Revenue in Prostate Cancer Screening Business ( 2016-2021)(Million US$)
Figure Roche Diagnostics Revenue Growth Rate in Prostate Cancer Screening Business ( 2016-2021)
Table Roche Diagnostics Recent Development
Table Rosetta Genomics Company Details
Table Rosetta Genomics Revenue in Prostate Cancer Screening Business ( 2016-2021)(Million US$)
Figure Rosetta Genomics Revenue Growth Rate in Prostate Cancer Screening Business ( 2016-2021)
Table Rosetta Genomics Recent Development
Table Thermo Fisher Scientific Company Details
Table Hologic Company Details
Table Myriad Genetics Company Details
Table Global Prostate Cancer Screening Market Size by Regions (Million US$) 2021-2027
Figure Global Prostate Cancer Screening Market Size Share by Regions ( 2021-2027)
Figure Global Prostate Cancer Screening Market Size Share by Regions in 2027
Figure United States Prostate Cancer Screening Market Size Forecast ( 2021-2027)(Million USD)
Figure Europe Prostate Cancer Screening Market Size Forecast ( 2021-2027)(Million USD)
Figure China Prostate Cancer Screening Market Size Forecast ( 2021-2027)(Million USD)
Figure Japan Prostate Cancer Screening Market Size Forecast ( 2021-2027)(Million USD)
Figure Southeast Asia Prostate Cancer Screening Market Size Forecast ( 2021-2027)(Million USD)
Figure India Prostate Cancer Screening Market Size Forecast ( 2021-2027)(Million USD)
Figure Central & South America Prostate Cancer Screening Market Size Forecast ( 2021-2027)(Million USD)
Table Global Prostate Cancer Screening Market Size by Product ( 2021-2027) (Million US$)
Figure Global Prostate Cancer Screening Market Size by Product ( 2021-2027)
Figure Global Prostate Cancer Screening Market Size by Product in 2027
Table Global Prostate Cancer Screening Market Size by Application ( 2021-2027) (Million US$)
Figure Global Prostate Cancer Screening Market Size by Application ( 2021-2027)
Figure Global Prostate Cancer Screening Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.